Report Detail

Other Global Drugs of Abuse Testing Market Insights, Forecast to 2025

  • RnM2716574
  • |
  • 02 January, 2019
  • |
  • Global
  • |
  • 110 Pages
  • |
  • QYResearch
  • |
  • Other

Drugs of abuse testing involves detection of one or more illegal and/or prescribed substances in the urine, blood, saliva, hair, or sweat. The process is carried out with the help of various techniques like Immunoassays Analyzers, Chromatography and Rapid Testing. Immunoassays Analyzers is the equipment that helps in biochemical tests that helps detect or quantify specific proteins or drug substances.
Among these technique types of the drugs of abuse testing market, the rapid testing segment is expected to grow at the highest rate with a 6.6% CAGR during the forecast period.
The global Drugs of Abuse Testing market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Drugs of Abuse Testing market based on company, product type, end user and key regions.

This report studies the global market size of Drugs of Abuse Testing in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Drugs of Abuse Testing in these regions.
This research report categorizes the global Drugs of Abuse Testing market by top players/brands, region, type and end user. This report also studies the global Drugs of Abuse Testing market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Quest Diagnostics
F. Hoffmann La-Roche
Siemens
Thermo Fisher Scientific
Alere
Shimadzu
Laboratory Corporation of America

Market size by Product
Psychostimulants
Narcotic
Hallucinogens
Sedatives
Others
Market size by End User
Hospitals
Diagnostics Laboratories
Forensic Laboratories
Others

Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Drugs of Abuse Testing market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Drugs of Abuse Testing market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Drugs of Abuse Testing companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Drugs of Abuse Testing submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Drugs of Abuse Testing are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Drugs of Abuse Testing market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.


Table of Contents

    1 Study Coverage

    • 1.1 Drugs of Abuse Testing Product
    • 1.2 Market Segments
    • 1.3 Key Manufacturers Covered
    • 1.4 Market by Type
      • 1.4.1 Global Drugs of Abuse Testing Market Size Growth Rate by Product
      • 1.4.2 Psychostimulants
      • 1.4.3 Narcotic
      • 1.4.4 Hallucinogens
      • 1.4.5 Sedatives
      • 1.4.6 Others
    • 1.5 Market by End User
      • 1.5.1 Global Drugs of Abuse Testing Market Size Growth Rate by End User
      • 1.5.2 Hospitals
      • 1.5.3 Diagnostics Laboratories
      • 1.5.4 Forensic Laboratories
      • 1.5.5 Others
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Executive Summary

    • 2.1 Global Drugs of Abuse Testing Market Size
      • 2.1.1 Global Drugs of Abuse Testing Revenue 2014-2025
      • 2.1.2 Global Drugs of Abuse Testing Sales 2014-2025
    • 2.2 Drugs of Abuse Testing Growth Rate by Regions
      • 2.2.1 Global Drugs of Abuse Testing Sales by Regions
      • 2.2.2 Global Drugs of Abuse Testing Revenue by Regions

    3 Breakdown Data by Manufacturers

    • 3.1 Drugs of Abuse Testing Sales by Manufacturers
      • 3.1.1 Drugs of Abuse Testing Sales by Manufacturers
      • 3.1.2 Drugs of Abuse Testing Sales Market Share by Manufacturers
      • 3.1.3 Global Drugs of Abuse Testing Market Concentration Ratio (CR5 and HHI)
    • 3.2 Drugs of Abuse Testing Revenue by Manufacturers
      • 3.2.1 Drugs of Abuse Testing Revenue by Manufacturers (2014-2019)
      • 3.2.2 Drugs of Abuse Testing Revenue Share by Manufacturers (2014-2019)
    • 3.3 Drugs of Abuse Testing Price by Manufacturers
    • 3.4 Drugs of Abuse Testing Manufacturing Base Distribution, Product Types
      • 3.4.1 Drugs of Abuse Testing Manufacturers Manufacturing Base Distribution, Headquarters
      • 3.4.2 Manufacturers Drugs of Abuse Testing Product Type
      • 3.4.3 Date of International Manufacturers Enter into Drugs of Abuse Testing Market
    • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Product

    • 4.1 Global Drugs of Abuse Testing Sales by Product
    • 4.2 Global Drugs of Abuse Testing Revenue by Product
    • 4.3 Drugs of Abuse Testing Price by Product

    5 Breakdown Data by End User

    • 5.1 Overview
    • 5.2 Global Drugs of Abuse Testing Breakdown Data by End User

    6 North America

    • 6.1 North America Drugs of Abuse Testing by Countries
      • 6.1.1 North America Drugs of Abuse Testing Sales by Countries
      • 6.1.2 North America Drugs of Abuse Testing Revenue by Countries
      • 6.1.3 United States
      • 6.1.4 Canada
      • 6.1.5 Mexico
    • 6.2 North America Drugs of Abuse Testing by Product
    • 6.3 North America Drugs of Abuse Testing by End User

    7 Europe

    • 7.1 Europe Drugs of Abuse Testing by Countries
      • 7.1.1 Europe Drugs of Abuse Testing Sales by Countries
      • 7.1.2 Europe Drugs of Abuse Testing Revenue by Countries
      • 7.1.3 Germany
      • 7.1.4 France
      • 7.1.5 UK
      • 7.1.6 Italy
      • 7.1.7 Russia
    • 7.2 Europe Drugs of Abuse Testing by Product
    • 7.3 Europe Drugs of Abuse Testing by End User

    8 Asia Pacific

    • 8.1 Asia Pacific Drugs of Abuse Testing by Countries
      • 8.1.1 Asia Pacific Drugs of Abuse Testing Sales by Countries
      • 8.1.2 Asia Pacific Drugs of Abuse Testing Revenue by Countries
      • 8.1.3 China
      • 8.1.4 Japan
      • 8.1.5 Korea
      • 8.1.6 India
      • 8.1.7 Australia
      • 8.1.8 Indonesia
      • 8.1.9 Malaysia
      • 8.1.10 Philippines
      • 8.1.11 Thailand
      • 8.1.12 Vietnam
      • 8.1.13 Singapore
    • 8.2 Asia Pacific Drugs of Abuse Testing by Product
    • 8.3 Asia Pacific Drugs of Abuse Testing by End User

    9 Central & South America

    • 9.1 Central & South America Drugs of Abuse Testing by Countries
      • 9.1.1 Central & South America Drugs of Abuse Testing Sales by Countries
      • 9.1.2 Central & South America Drugs of Abuse Testing Revenue by Countries
      • 9.1.3 Brazil
    • 9.2 Central & South America Drugs of Abuse Testing by Product
    • 9.3 Central & South America Drugs of Abuse Testing by End User

    10 Middle East and Africa

    • 10.1 Middle East and Africa Drugs of Abuse Testing by Countries
      • 10.1.1 Middle East and Africa Drugs of Abuse Testing Sales by Countries
      • 10.1.2 Middle East and Africa Drugs of Abuse Testing Revenue by Countries
      • 10.1.3 GCC Countries
      • 10.1.4 Turkey
      • 10.1.5 Egypt
      • 10.1.6 South Africa
    • 10.2 Middle East and Africa Drugs of Abuse Testing by Product
    • 10.3 Middle East and Africa Drugs of Abuse Testing by End User

    11 Company Profiles

    • 11.1 Quest Diagnostics
      • 11.1.1 Quest Diagnostics Company Details
      • 11.1.2 Company Business Overview
      • 11.1.3 Quest Diagnostics Drugs of Abuse Testing Sales, Revenue and Gross Margin (2014-2019)
      • 11.1.4 Quest Diagnostics Drugs of Abuse Testing Products Offered
      • 11.1.5 Quest Diagnostics Recent Development
    • 11.2 F. Hoffmann La-Roche
      • 11.2.1 F. Hoffmann La-Roche Company Details
      • 11.2.2 Company Business Overview
      • 11.2.3 F. Hoffmann La-Roche Drugs of Abuse Testing Sales, Revenue and Gross Margin (2014-2019)
      • 11.2.4 F. Hoffmann La-Roche Drugs of Abuse Testing Products Offered
      • 11.2.5 F. Hoffmann La-Roche Recent Development
    • 11.3 Siemens
      • 11.3.1 Siemens Company Details
      • 11.3.2 Company Business Overview
    • 11.3.Siemens Drugs of Abuse Testing Sales, Revenue and Gross Margin (2014-2019)
      • 11.3.4 Siemens Drugs of Abuse Testing Products Offered
      • 11.3.5 Siemens Recent Development
    • 11.4 Thermo Fisher Scientific
      • 11.4.1 Thermo Fisher Scientific Company Details
      • 11.4.2 Company Business Overview
      • 11.4.3 Thermo Fisher Scientific Drugs of Abuse Testing Sales, Revenue and Gross Margin (2014-2019)
      • 11.4.4 Thermo Fisher Scientific Drugs of Abuse Testing Products Offered
      • 11.4.5 Thermo Fisher Scientific Recent Development
    • 11.5 Alere
      • 11.5.1 Alere Company Details
      • 11.5.2 Company Business Overview
      • 11.5.3 Alere Drugs of Abuse Testing Sales, Revenue and Gross Margin (2014-2019)
      • 11.5.4 Alere Drugs of Abuse Testing Products Offered
      • 11.5.5 Alere Recent Development
    • 11.6 Shimadzu
      • 11.6.1 Shimadzu Company Details
      • 11.6.2 Company Business Overview
      • 11.6.3 Shimadzu Drugs of Abuse Testing Sales, Revenue and Gross Margin (2014-2019)
      • 11.6.4 Shimadzu Drugs of Abuse Testing Products Offered
      • 11.6.5 Shimadzu Recent Development
    • 11.7 Laboratory Corporation of America
      • 11.7.1 Laboratory Corporation of America Company Details
      • 11.7.2 Company Business Overview
      • 11.7.3 Laboratory Corporation of America Drugs of Abuse Testing Sales, Revenue and Gross Margin (2014-2019)
      • 11.7.4 Laboratory Corporation of America Drugs of Abuse Testing Products Offered
      • 11.7.5 Laboratory Corporation of America Recent Development

    12 Future Forecast

    • 12.1 Drugs of Abuse Testing Market Forecast by Regions
      • 12.1.1 Global Drugs of Abuse Testing Sales Forecast by Regions 2019-2025
      • 12.1.2 Global Drugs of Abuse Testing Revenue Forecast by Regions 2019-2025
    • 12.2 Drugs of Abuse Testing Market Forecast by Product
      • 12.2.1 Global Drugs of Abuse Testing Sales Forecast by Product 2019-2025
      • 12.2.2 Global Drugs of Abuse Testing Revenue Forecast by Product 2019-2025
    • 12.3 Drugs of Abuse Testing Market Forecast by End User
    • 12.4 North America Drugs of Abuse Testing Forecast
    • 12.5 Europe Drugs of Abuse Testing Forecast
    • 12.6 Asia Pacific Drugs of Abuse Testing Forecast
    • 12.7 Central & South America Drugs of Abuse Testing Forecast
    • 12.8 Middle East and Africa Drugs of Abuse Testing Forecast

    13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

    • 13.1 Market Opportunities and Drivers
    • 13.2 Market Challenges
    • 13.3 Market Risks/Restraints
    • 13.4 Macroscopic Indicators

    14 Value Chain and Sales Channels Analysis

    • 14.1 Value Chain Analysis
    • 14.2 Drugs of Abuse Testing Customers
    • 14.3 Sales Channels Analysis
      • 14.3.1 Sales Channels
      • 14.3.2 Distributors

    15 Research Findings and Conclusion

      16 Appendix

      • 16.1 Research Methodology
        • 16.1.1 Methodology/Research Approach
        • 16.1.2 Data Source
      • 16.2 Author Details

      Summary:
      Get latest Market Research Reports on Drugs of Abuse Testing . Industry analysis & Market Report on Drugs of Abuse Testing is a syndicated market report, published as Global Drugs of Abuse Testing Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Drugs of Abuse Testing market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $4,900.00
      $9,800.00
      3,880.80
      7,761.60
      4,527.60
      9,055.20
      741,321.00
      1,482,642.00
      408,513.00
      817,026.00
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report